Thomas Mørch Klemmensen

Thomas Mørch Klemmensen currently serves as Head of Corporate Project & Strategy Office at Fertin Pharma A/S since September 2022. Prior to this role, Thomas worked as a Business Developer at the University of Southern Denmark from August 2019 to September 2022. Thomas has extensive experience at Lundbeck, where roles included PA to the CEO, Head of Corporate Secretariat & Project Office, and Commercial Analyst in the Department of Market Research & Competitive Intelligence. Additional professional experience includes positions as Clinical Safety Officer at ALK-Abelló A/S and Academic Research Scientist at Statens Serum Institut. Thomas holds a Graduate Diploma in Business Administration from Copenhagen Business School, an MSc in Human Biology, and a BSc in Industry Bachelor of Biology, both from the University of Copenhagen.